nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP3A4—Pilocarpine—glaucoma	0.0554	0.236	CbGbCtD
Levonorgestrel—CYP3A4—Brinzolamide—glaucoma	0.0435	0.185	CbGbCtD
Levonorgestrel—CYP3A4—Dorzolamide—glaucoma	0.042	0.178	CbGbCtD
Levonorgestrel—CYP3A4—Methazolamide—glaucoma	0.0374	0.159	CbGbCtD
Levonorgestrel—CYP3A4—Acetazolamide—glaucoma	0.0299	0.127	CbGbCtD
Levonorgestrel—CYP3A4—Clonidine—glaucoma	0.0271	0.115	CbGbCtD
Levonorgestrel—CYP19A1—Endogenous sterols—CYP1B1—glaucoma	0.00169	0.0164	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00158	0.0154	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00158	0.0153	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00145	0.0141	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CA5A—glaucoma	0.00137	0.0133	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NARFL—glaucoma	0.00137	0.0133	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptors—NR3C1—glaucoma	0.00127	0.0124	CbGpPWpGaD
Levonorgestrel—CYP19A1—FSH signaling pathway—BDNF—glaucoma	0.00124	0.0121	CbGpPWpGaD
Levonorgestrel—CYP19A1—Ovarian Infertility Genes—CCND2—glaucoma	0.00122	0.0118	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00121	0.0118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00104	0.0101	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—SOD1—glaucoma	0.00104	0.0101	CbGpPWpGaD
Levonorgestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00102	0.0099	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.00101	0.00982	CbGpPWpGaD
Levonorgestrel—PGR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00101	0.00977	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptors—NR3C1—glaucoma	0.00097	0.00942	CbGpPWpGaD
Levonorgestrel—CYP19A1—Tryptophan metabolism—CYP1B1—glaucoma	0.000969	0.00941	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000867	0.00842	CbGpPWpGaD
Levonorgestrel—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000843	0.00819	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.000836	0.00812	CbGpPWpGaD
Levonorgestrel—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.000811	0.00788	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000802	0.00778	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.000801	0.00778	CbGpPWpGaD
Levonorgestrel—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000783	0.00761	CbGpPWpGaD
Levonorgestrel—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000773	0.00751	CbGpPWpGaD
Levonorgestrel—AR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000767	0.00745	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.000748	0.00726	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.000748	0.00726	CbGpPWpGaD
Levonorgestrel—AR—Regulation of Androgen receptor activity—NR3C1—glaucoma	0.000744	0.00722	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—glaucoma	0.00068	0.0066	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CA1—glaucoma	0.000667	0.00648	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000664	0.00645	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CTSA—glaucoma	0.000646	0.00627	CbGpPWpGaD
Levonorgestrel—Progesterone—CYP1B1—glaucoma	0.000641	0.306	CrCbGaD
Levonorgestrel—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000635	0.00617	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CA2—glaucoma	0.00061	0.00593	CbGpPWpGaD
Levonorgestrel—Testosterone—CYP1B1—glaucoma	0.000606	0.289	CrCbGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000604	0.00586	CbGpPWpGaD
Levonorgestrel—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000599	0.00582	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000596	0.00579	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000596	0.00579	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000594	0.00576	CbGpPWpGaD
Levonorgestrel—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000591	0.00574	CbGpPWpGaD
Levonorgestrel—CYP19A1—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000553	0.00537	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00053	0.00514	CbGpPWpGaD
Levonorgestrel—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000529	0.00514	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000501	0.00487	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.0005	0.00486	CbGpPWpGaD
Levonorgestrel—AR—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000498	0.00484	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000491	0.00476	CbGpPWpGaD
Levonorgestrel—Somnolence—Brinzolamide—glaucoma	0.000487	0.000738	CcSEcCtD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.000486	0.00472	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Dorzolamide—glaucoma	0.000484	0.000734	CcSEcCtD
Levonorgestrel—Urticaria—Acetazolamide—glaucoma	0.000482	0.000731	CcSEcCtD
Levonorgestrel—Dyspepsia—Brinzolamide—glaucoma	0.000482	0.00073	CcSEcCtD
Levonorgestrel—Eye disorder—Betaxolol—glaucoma	0.000481	0.000729	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000481	0.00467	CbGpPWpGaD
Levonorgestrel—Pruritus—Apraclonidine—glaucoma	0.00048	0.000728	CcSEcCtD
Levonorgestrel—Body temperature increased—Acetazolamide—glaucoma	0.00048	0.000728	CcSEcCtD
Levonorgestrel—Fatigue—Dorzolamide—glaucoma	0.00048	0.000728	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000479	0.000727	CcSEcCtD
Levonorgestrel—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000479	0.00465	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Travoprost—glaucoma	0.000478	0.000725	CcSEcCtD
Levonorgestrel—Fatigue—Travoprost—glaucoma	0.000478	0.000724	CcSEcCtD
Levonorgestrel—Cardiac disorder—Betaxolol—glaucoma	0.000478	0.000724	CcSEcCtD
Levonorgestrel—Pain—Dorzolamide—glaucoma	0.000476	0.000722	CcSEcCtD
Levonorgestrel—Insomnia—Pilocarpine—glaucoma	0.000476	0.000721	CcSEcCtD
Levonorgestrel—Decreased appetite—Brinzolamide—glaucoma	0.000476	0.000721	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000476	0.00462	CbGpPWpGaD
Levonorgestrel—Weight decreased—Timolol—glaucoma	0.000475	0.000721	CcSEcCtD
Levonorgestrel—Constipation—Travoprost—glaucoma	0.000474	0.000719	CcSEcCtD
Levonorgestrel—Pain—Travoprost—glaucoma	0.000474	0.000719	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000472	0.000716	CcSEcCtD
Levonorgestrel—AR—Notch-mediated HES/HEY network—CDKN1B—glaucoma	0.000472	0.00459	CbGpPWpGaD
Levonorgestrel—Asthenia—Bimatoprost—glaucoma	0.000472	0.000716	CcSEcCtD
Levonorgestrel—Fatigue—Brinzolamide—glaucoma	0.000472	0.000715	CcSEcCtD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000471	0.00457	CbGpPWpGaD
Levonorgestrel—Angioedema—Clonidine—glaucoma	0.00047	0.000713	CcSEcCtD
Levonorgestrel—Dyspnoea—Pilocarpine—glaucoma	0.000469	0.000711	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000469	0.00455	CbGpPWpGaD
Levonorgestrel—Hydrocortisone—NR3C1—glaucoma	0.000468	0.223	CrCbGaD
Levonorgestrel—Pain—Brinzolamide—glaucoma	0.000468	0.000709	CcSEcCtD
Levonorgestrel—Somnolence—Pilocarpine—glaucoma	0.000468	0.000709	CcSEcCtD
Levonorgestrel—Depression—Timolol—glaucoma	0.000467	0.000708	CcSEcCtD
Levonorgestrel—Pruritus—Bimatoprost—glaucoma	0.000466	0.000706	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000465	0.00451	CbGpPWpGaD
Levonorgestrel—Immune system disorder—Betaxolol—glaucoma	0.000465	0.000705	CcSEcCtD
Levonorgestrel—Diarrhoea—Apraclonidine—glaucoma	0.000465	0.000704	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Betaxolol—glaucoma	0.000464	0.000703	CcSEcCtD
Levonorgestrel—Dyspepsia—Pilocarpine—glaucoma	0.000463	0.000702	CcSEcCtD
Levonorgestrel—Syncope—Clonidine—glaucoma	0.000462	0.0007	CcSEcCtD
Levonorgestrel—Arrhythmia—Betaxolol—glaucoma	0.00046	0.000697	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000459	0.00445	CbGpPWpGaD
Levonorgestrel—Decreased appetite—Pilocarpine—glaucoma	0.000457	0.000693	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dorzolamide—glaucoma	0.000455	0.00069	CcSEcCtD
Levonorgestrel—Alopecia—Betaxolol—glaucoma	0.000455	0.00069	CcSEcCtD
Levonorgestrel—Palpitations—Clonidine—glaucoma	0.000455	0.00069	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000454	0.000688	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Travoprost—glaucoma	0.000453	0.000687	CcSEcCtD
Levonorgestrel—Loss of consciousness—Clonidine—glaucoma	0.000452	0.000686	CcSEcCtD
Levonorgestrel—Mental disorder—Betaxolol—glaucoma	0.000451	0.000684	CcSEcCtD
Levonorgestrel—Pain—Pilocarpine—glaucoma	0.00045	0.000682	CcSEcCtD
Levonorgestrel—Constipation—Pilocarpine—glaucoma	0.00045	0.000682	CcSEcCtD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.00045	0.00437	CbGpPWpGaD
Levonorgestrel—Cough—Clonidine—glaucoma	0.000449	0.000681	CcSEcCtD
Levonorgestrel—Dizziness—Apraclonidine—glaucoma	0.000449	0.000681	CcSEcCtD
Levonorgestrel—Erythema—Betaxolol—glaucoma	0.000448	0.000679	CcSEcCtD
Levonorgestrel—Malnutrition—Betaxolol—glaucoma	0.000448	0.000679	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000442	0.00429	CbGpPWpGaD
Levonorgestrel—Urticaria—Dorzolamide—glaucoma	0.000442	0.00067	CcSEcCtD
Levonorgestrel—Abdominal pain—Dorzolamide—glaucoma	0.00044	0.000667	CcSEcCtD
Levonorgestrel—Body temperature increased—Dorzolamide—glaucoma	0.00044	0.000667	CcSEcCtD
Levonorgestrel—Tension—Betaxolol—glaucoma	0.00044	0.000667	CcSEcCtD
Levonorgestrel—Sinusitis—Timolol—glaucoma	0.000439	0.000666	CcSEcCtD
Levonorgestrel—Chest pain—Clonidine—glaucoma	0.000438	0.000664	CcSEcCtD
Levonorgestrel—Abdominal pain—Travoprost—glaucoma	0.000438	0.000664	CcSEcCtD
Levonorgestrel—Anxiety—Clonidine—glaucoma	0.000437	0.000662	CcSEcCtD
Levonorgestrel—Asthenia—Acetazolamide—glaucoma	0.000436	0.000661	CcSEcCtD
Levonorgestrel—Dizziness—Bimatoprost—glaucoma	0.000435	0.00066	CcSEcCtD
Levonorgestrel—Nervousness—Betaxolol—glaucoma	0.000435	0.00066	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000435	0.00066	CcSEcCtD
Levonorgestrel—Urticaria—Brinzolamide—glaucoma	0.000435	0.000659	CcSEcCtD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CDKN2A—glaucoma	0.000433	0.0042	CbGpPWpGaD
Levonorgestrel—Discomfort—Clonidine—glaucoma	0.000433	0.000656	CcSEcCtD
Levonorgestrel—AR—Androgen receptor signaling pathway—CAV1—glaucoma	0.000433	0.0042	CbGpPWpGaD
Levonorgestrel—Vomiting—Apraclonidine—glaucoma	0.000432	0.000654	CcSEcCtD
Levonorgestrel—Muscle spasms—Betaxolol—glaucoma	0.000431	0.000653	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Pilocarpine—glaucoma	0.00043	0.000652	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—TXN—glaucoma	0.00043	0.00417	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Brimonidine—glaucoma	0.000429	0.000651	CcSEcCtD
Levonorgestrel—Dermatitis—Apraclonidine—glaucoma	0.000428	0.000648	CcSEcCtD
Levonorgestrel—Headache—Apraclonidine—glaucoma	0.000425	0.000645	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—GSTT1—glaucoma	0.000423	0.00411	CbGpPWpGaD
Levonorgestrel—Rhinitis—Timolol—glaucoma	0.000422	0.000639	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000421	0.00409	CbGpPWpGaD
Levonorgestrel—Oedema—Clonidine—glaucoma	0.00042	0.000637	CcSEcCtD
Levonorgestrel—Asthenia—Brimonidine—glaucoma	0.000418	0.000634	CcSEcCtD
Levonorgestrel—Infection—Clonidine—glaucoma	0.000417	0.000633	CcSEcCtD
Levonorgestrel—Body temperature increased—Pilocarpine—glaucoma	0.000416	0.00063	CcSEcCtD
Levonorgestrel—Abdominal pain—Pilocarpine—glaucoma	0.000416	0.00063	CcSEcCtD
Levonorgestrel—Diarrhoea—Acetazolamide—glaucoma	0.000416	0.00063	CcSEcCtD
Levonorgestrel—Rash—Bimatoprost—glaucoma	0.000415	0.000629	CcSEcCtD
Levonorgestrel—Dermatitis—Bimatoprost—glaucoma	0.000415	0.000629	CcSEcCtD
Levonorgestrel—Anaemia—Betaxolol—glaucoma	0.000414	0.000628	CcSEcCtD
Levonorgestrel—Shock—Clonidine—glaucoma	0.000413	0.000627	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Timolol—glaucoma	0.000413	0.000626	CcSEcCtD
Levonorgestrel—Pruritus—Brimonidine—glaucoma	0.000412	0.000625	CcSEcCtD
Levonorgestrel—Headache—Bimatoprost—glaucoma	0.000412	0.000625	CcSEcCtD
Levonorgestrel—Nervous system disorder—Clonidine—glaucoma	0.000412	0.000625	CcSEcCtD
Levonorgestrel—Hypersensitivity—Dorzolamide—glaucoma	0.00041	0.000622	CcSEcCtD
Levonorgestrel—Hypersensitivity—Travoprost—glaucoma	0.000408	0.000619	CcSEcCtD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.000408	0.00396	CbGpPWpGaD
Levonorgestrel—Skin disorder—Clonidine—glaucoma	0.000408	0.000619	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Clonidine—glaucoma	0.000406	0.000616	CcSEcCtD
Levonorgestrel—Visual impairment—Timolol—glaucoma	0.000405	0.000614	CcSEcCtD
Levonorgestrel—Nausea—Apraclonidine—glaucoma	0.000403	0.000611	CcSEcCtD
Levonorgestrel—Hypersensitivity—Brinzolamide—glaucoma	0.000403	0.000611	CcSEcCtD
Levonorgestrel—Vertigo—Betaxolol—glaucoma	0.000403	0.00061	CcSEcCtD
Levonorgestrel—Syncope—Betaxolol—glaucoma	0.000402	0.000609	CcSEcCtD
Levonorgestrel—Dizziness—Acetazolamide—glaucoma	0.000402	0.000609	CcSEcCtD
Levonorgestrel—Anorexia—Clonidine—glaucoma	0.0004	0.000607	CcSEcCtD
Levonorgestrel—Asthenia—Dorzolamide—glaucoma	0.000399	0.000605	CcSEcCtD
Levonorgestrel—Asthenia—Travoprost—glaucoma	0.000398	0.000603	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000397	0.00385	CbGpPWpGaD
Levonorgestrel—Palpitations—Betaxolol—glaucoma	0.000396	0.0006	CcSEcCtD
Levonorgestrel—Pruritus—Dorzolamide—glaucoma	0.000394	0.000597	CcSEcCtD
Levonorgestrel—Loss of consciousness—Betaxolol—glaucoma	0.000394	0.000597	CcSEcCtD
Levonorgestrel—Eye disorder—Timolol—glaucoma	0.000393	0.000596	CcSEcCtD
Levonorgestrel—Asthenia—Brinzolamide—glaucoma	0.000393	0.000595	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.000392	0.00381	CbGpPWpGaD
Levonorgestrel—Pruritus—Travoprost—glaucoma	0.000392	0.000595	CcSEcCtD
Levonorgestrel—Cough—Betaxolol—glaucoma	0.000391	0.000593	CcSEcCtD
Levonorgestrel—Nausea—Bimatoprost—glaucoma	0.000391	0.000593	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000391	0.0038	CbGpPWpGaD
Levonorgestrel—Cardiac disorder—Timolol—glaucoma	0.00039	0.000592	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.000389	0.00377	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Pilocarpine—glaucoma	0.000388	0.000588	CcSEcCtD
Levonorgestrel—Pruritus—Brinzolamide—glaucoma	0.000387	0.000587	CcSEcCtD
Levonorgestrel—Vomiting—Acetazolamide—glaucoma	0.000386	0.000585	CcSEcCtD
Levonorgestrel—Dizziness—Brimonidine—glaucoma	0.000385	0.000584	CcSEcCtD
Levonorgestrel—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000384	0.00372	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Clonidine—glaucoma	0.000383	0.00058	CcSEcCtD
Levonorgestrel—Chest pain—Betaxolol—glaucoma	0.000381	0.000578	CcSEcCtD
Levonorgestrel—Myalgia—Betaxolol—glaucoma	0.000381	0.000578	CcSEcCtD
Levonorgestrel—Progesterone—NR3C1—glaucoma	0.000381	0.182	CrCbGaD
Levonorgestrel—Diarrhoea—Dorzolamide—glaucoma	0.000381	0.000577	CcSEcCtD
Levonorgestrel—Headache—Acetazolamide—glaucoma	0.00038	0.000577	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—glaucoma	0.00038	0.00369	CbGpPWpGaD
Levonorgestrel—Anxiety—Betaxolol—glaucoma	0.00038	0.000576	CcSEcCtD
Levonorgestrel—Insomnia—Clonidine—glaucoma	0.00038	0.000576	CcSEcCtD
Levonorgestrel—Immune system disorder—Timolol—glaucoma	0.00038	0.000576	CcSEcCtD
Levonorgestrel—Diarrhoea—Travoprost—glaucoma	0.000379	0.000575	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Timolol—glaucoma	0.000379	0.000575	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000379	0.000574	CcSEcCtD
Levonorgestrel—Asthenia—Pilocarpine—glaucoma	0.000377	0.000572	CcSEcCtD
Levonorgestrel—Discomfort—Betaxolol—glaucoma	0.000377	0.000571	CcSEcCtD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000376	0.00365	CbGpPWpGaD
Levonorgestrel—Arrhythmia—Timolol—glaucoma	0.000376	0.00057	CcSEcCtD
Levonorgestrel—Dyspnoea—Clonidine—glaucoma	0.000374	0.000568	CcSEcCtD
Levonorgestrel—Diarrhoea—Brinzolamide—glaucoma	0.000374	0.000568	CcSEcCtD
Levonorgestrel—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000374	0.00363	CbGpPWpGaD
Levonorgestrel—Somnolence—Clonidine—glaucoma	0.000373	0.000566	CcSEcCtD
Levonorgestrel—Pruritus—Pilocarpine—glaucoma	0.000372	0.000564	CcSEcCtD
Levonorgestrel—Alopecia—Timolol—glaucoma	0.000372	0.000563	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.00037	0.00359	CbGpPWpGaD
Levonorgestrel—Mental disorder—Timolol—glaucoma	0.000368	0.000559	CcSEcCtD
Levonorgestrel—Dizziness—Dorzolamide—glaucoma	0.000368	0.000558	CcSEcCtD
Levonorgestrel—Rash—Brimonidine—glaucoma	0.000368	0.000557	CcSEcCtD
Levonorgestrel—Dermatitis—Brimonidine—glaucoma	0.000367	0.000557	CcSEcCtD
Levonorgestrel—Dizziness—Travoprost—glaucoma	0.000367	0.000556	CcSEcCtD
Levonorgestrel—Erythema—Timolol—glaucoma	0.000366	0.000555	CcSEcCtD
Levonorgestrel—Malnutrition—Timolol—glaucoma	0.000366	0.000555	CcSEcCtD
Levonorgestrel—Oedema—Betaxolol—glaucoma	0.000366	0.000554	CcSEcCtD
Levonorgestrel—Headache—Brimonidine—glaucoma	0.000365	0.000554	CcSEcCtD
Levonorgestrel—Decreased appetite—Clonidine—glaucoma	0.000365	0.000554	CcSEcCtD
Levonorgestrel—Infection—Betaxolol—glaucoma	0.000363	0.000551	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Clonidine—glaucoma	0.000363	0.00055	CcSEcCtD
Levonorgestrel—Fatigue—Clonidine—glaucoma	0.000362	0.000549	CcSEcCtD
Levonorgestrel—Dizziness—Brinzolamide—glaucoma	0.000362	0.000549	CcSEcCtD
Levonorgestrel—Nausea—Acetazolamide—glaucoma	0.000361	0.000547	CcSEcCtD
Levonorgestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00036	0.0035	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Pilocarpine—glaucoma	0.00036	0.000546	CcSEcCtD
Levonorgestrel—Shock—Betaxolol—glaucoma	0.00036	0.000545	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—BAD—glaucoma	0.00036	0.00349	CbGpPWpGaD
Levonorgestrel—Tension—Timolol—glaucoma	0.000359	0.000545	CcSEcCtD
Levonorgestrel—Pain—Clonidine—glaucoma	0.000359	0.000545	CcSEcCtD
Levonorgestrel—Constipation—Clonidine—glaucoma	0.000359	0.000545	CcSEcCtD
Levonorgestrel—Nervous system disorder—Betaxolol—glaucoma	0.000359	0.000544	CcSEcCtD
Levonorgestrel—Nervousness—Timolol—glaucoma	0.000356	0.000539	CcSEcCtD
Levonorgestrel—Skin disorder—Betaxolol—glaucoma	0.000355	0.000539	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000355	0.00345	CbGpPWpGaD
Levonorgestrel—Vomiting—Dorzolamide—glaucoma	0.000354	0.000537	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Betaxolol—glaucoma	0.000354	0.000536	CcSEcCtD
Levonorgestrel—Rash—Dorzolamide—glaucoma	0.000351	0.000532	CcSEcCtD
Levonorgestrel—Dermatitis—Dorzolamide—glaucoma	0.000351	0.000532	CcSEcCtD
Levonorgestrel—Rash—Travoprost—glaucoma	0.000349	0.00053	CcSEcCtD
Levonorgestrel—Dermatitis—Travoprost—glaucoma	0.000349	0.000529	CcSEcCtD
Levonorgestrel—Headache—Dorzolamide—glaucoma	0.000349	0.000529	CcSEcCtD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—glaucoma	0.000349	0.00338	CbGpPWpGaD
Levonorgestrel—Anorexia—Betaxolol—glaucoma	0.000349	0.000528	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—BAD—glaucoma	0.000348	0.00338	CbGpPWpGaD
Levonorgestrel—Vomiting—Brinzolamide—glaucoma	0.000348	0.000528	CcSEcCtD
Levonorgestrel—Dizziness—Pilocarpine—glaucoma	0.000348	0.000527	CcSEcCtD
Levonorgestrel—Headache—Travoprost—glaucoma	0.000347	0.000526	CcSEcCtD
Levonorgestrel—Nausea—Brimonidine—glaucoma	0.000346	0.000525	CcSEcCtD
Levonorgestrel—Rash—Brinzolamide—glaucoma	0.000345	0.000523	CcSEcCtD
Levonorgestrel—Dermatitis—Brinzolamide—glaucoma	0.000345	0.000523	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Clonidine—glaucoma	0.000343	0.000521	CcSEcCtD
Levonorgestrel—Headache—Brinzolamide—glaucoma	0.000343	0.00052	CcSEcCtD
Levonorgestrel—AR—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000341	0.00331	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000341	0.00331	CbGpPWpGaD
Levonorgestrel—CYP19A1—Biological oxidations—CYP1B1—glaucoma	0.000337	0.00328	CbGpPWpGaD
Levonorgestrel—Angioedema—Timolol—glaucoma	0.000334	0.000507	CcSEcCtD
Levonorgestrel—Vomiting—Pilocarpine—glaucoma	0.000334	0.000507	CcSEcCtD
Levonorgestrel—Urticaria—Clonidine—glaucoma	0.000334	0.000506	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GSTT1—glaucoma	0.000333	0.00324	CbGpPWpGaD
Levonorgestrel—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000333	0.000505	CcSEcCtD
Levonorgestrel—CYP19A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000333	0.00323	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Clonidine—glaucoma	0.000332	0.000503	CcSEcCtD
Levonorgestrel—Abdominal pain—Clonidine—glaucoma	0.000332	0.000503	CcSEcCtD
Levonorgestrel—Rash—Pilocarpine—glaucoma	0.000332	0.000503	CcSEcCtD
Levonorgestrel—Dermatitis—Pilocarpine—glaucoma	0.000331	0.000502	CcSEcCtD
Levonorgestrel—Insomnia—Betaxolol—glaucoma	0.000331	0.000501	CcSEcCtD
Levonorgestrel—Nausea—Dorzolamide—glaucoma	0.000331	0.000501	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00033	0.0032	CbGpPWpGaD
Levonorgestrel—Headache—Pilocarpine—glaucoma	0.00033	0.0005	CcSEcCtD
Levonorgestrel—Nausea—Travoprost—glaucoma	0.000329	0.000499	CcSEcCtD
Levonorgestrel—Vertigo—Timolol—glaucoma	0.000329	0.000499	CcSEcCtD
Levonorgestrel—Syncope—Timolol—glaucoma	0.000328	0.000498	CcSEcCtD
Levonorgestrel—Dyspnoea—Betaxolol—glaucoma	0.000326	0.000494	CcSEcCtD
Levonorgestrel—Nausea—Brinzolamide—glaucoma	0.000325	0.000493	CcSEcCtD
Levonorgestrel—Palpitations—Timolol—glaucoma	0.000323	0.00049	CcSEcCtD
Levonorgestrel—Dyspepsia—Betaxolol—glaucoma	0.000322	0.000488	CcSEcCtD
Levonorgestrel—Loss of consciousness—Timolol—glaucoma	0.000322	0.000488	CcSEcCtD
Levonorgestrel—Cough—Timolol—glaucoma	0.000319	0.000484	CcSEcCtD
Levonorgestrel—Decreased appetite—Betaxolol—glaucoma	0.000318	0.000482	CcSEcCtD
Levonorgestrel—Hypertension—Timolol—glaucoma	0.000316	0.000479	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Betaxolol—glaucoma	0.000316	0.000479	CcSEcCtD
Levonorgestrel—Fatigue—Betaxolol—glaucoma	0.000315	0.000478	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000315	0.00306	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NGF—glaucoma	0.000315	0.00306	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000314	0.00304	CbGpPWpGaD
Levonorgestrel—Pain—Betaxolol—glaucoma	0.000313	0.000474	CcSEcCtD
Levonorgestrel—Constipation—Betaxolol—glaucoma	0.000313	0.000474	CcSEcCtD
Levonorgestrel—Nausea—Pilocarpine—glaucoma	0.000312	0.000474	CcSEcCtD
Levonorgestrel—Myalgia—Timolol—glaucoma	0.000312	0.000472	CcSEcCtD
Levonorgestrel—Chest pain—Timolol—glaucoma	0.000312	0.000472	CcSEcCtD
Levonorgestrel—Anxiety—Timolol—glaucoma	0.000311	0.000471	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000309	0.000469	CcSEcCtD
Levonorgestrel—Hypersensitivity—Clonidine—glaucoma	0.000309	0.000469	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000308	0.00299	CbGpPWpGaD
Levonorgestrel—Discomfort—Timolol—glaucoma	0.000308	0.000467	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000304	0.00295	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000302	0.00293	CbGpPWpGaD
Levonorgestrel—Asthenia—Clonidine—glaucoma	0.000301	0.000457	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000299	0.0029	CbGpPWpGaD
Levonorgestrel—Oedema—Timolol—glaucoma	0.000299	0.000453	CcSEcCtD
Levonorgestrel—Pruritus—Clonidine—glaucoma	0.000297	0.000451	CcSEcCtD
Levonorgestrel—Infection—Timolol—glaucoma	0.000297	0.00045	CcSEcCtD
Levonorgestrel—CYP19A1—Metabolism—CA5A—glaucoma	0.000297	0.00288	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NARFL—glaucoma	0.000297	0.00288	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000296	0.00287	CbGpPWpGaD
Levonorgestrel—Shock—Timolol—glaucoma	0.000294	0.000446	CcSEcCtD
Levonorgestrel—Nervous system disorder—Timolol—glaucoma	0.000293	0.000444	CcSEcCtD
Levonorgestrel—Urticaria—Betaxolol—glaucoma	0.000291	0.00044	CcSEcCtD
Levonorgestrel—Skin disorder—Timolol—glaucoma	0.00029	0.00044	CcSEcCtD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.00029	0.00281	CbGpPWpGaD
Levonorgestrel—Body temperature increased—Betaxolol—glaucoma	0.000289	0.000438	CcSEcCtD
Levonorgestrel—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000289	0.00281	CbGpPWpGaD
Levonorgestrel—Hyperhidrosis—Timolol—glaucoma	0.000289	0.000438	CcSEcCtD
Levonorgestrel—Diarrhoea—Clonidine—glaucoma	0.000287	0.000436	CcSEcCtD
Levonorgestrel—PGR—Signaling Pathways—LRP12—glaucoma	0.000287	0.00278	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—glaucoma	0.000286	0.00278	CbGpPWpGaD
Levonorgestrel—Anorexia—Timolol—glaucoma	0.000285	0.000432	CcSEcCtD
Levonorgestrel—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000283	0.00275	CbGpPWpGaD
Levonorgestrel—Dizziness—Clonidine—glaucoma	0.000278	0.000421	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Timolol—glaucoma	0.000272	0.000413	CcSEcCtD
Levonorgestrel—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.000271	0.00263	CbGpPWpGaD
Levonorgestrel—Insomnia—Timolol—glaucoma	0.00027	0.00041	CcSEcCtD
Levonorgestrel—CYP19A1—Biological oxidations—GSTM1—glaucoma	0.00027	0.00262	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Betaxolol—glaucoma	0.000269	0.000408	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.000269	0.00261	CbGpPWpGaD
Levonorgestrel—Vomiting—Clonidine—glaucoma	0.000267	0.000405	CcSEcCtD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000267	0.00259	CbGpPWpGaD
Levonorgestrel—Dyspnoea—Timolol—glaucoma	0.000266	0.000404	CcSEcCtD
Levonorgestrel—CYP19A1—Metapathway biotransformation—GSTM1—glaucoma	0.000266	0.00258	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—ABCA1—glaucoma	0.000266	0.00258	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CYP1B1—glaucoma	0.000266	0.00258	CbGpPWpGaD
Levonorgestrel—Somnolence—Timolol—glaucoma	0.000266	0.000403	CcSEcCtD
Levonorgestrel—Rash—Clonidine—glaucoma	0.000265	0.000402	CcSEcCtD
Levonorgestrel—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000265	0.00257	CbGpPWpGaD
Levonorgestrel—Dermatitis—Clonidine—glaucoma	0.000265	0.000401	CcSEcCtD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000264	0.00256	CbGpPWpGaD
Levonorgestrel—Headache—Clonidine—glaucoma	0.000263	0.000399	CcSEcCtD
Levonorgestrel—Dyspepsia—Timolol—glaucoma	0.000263	0.000399	CcSEcCtD
Levonorgestrel—Asthenia—Betaxolol—glaucoma	0.000262	0.000398	CcSEcCtD
Levonorgestrel—Decreased appetite—Timolol—glaucoma	0.00026	0.000394	CcSEcCtD
Levonorgestrel—Pruritus—Betaxolol—glaucoma	0.000259	0.000392	CcSEcCtD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000258	0.00251	CbGpPWpGaD
Levonorgestrel—Gastrointestinal disorder—Timolol—glaucoma	0.000258	0.000391	CcSEcCtD
Levonorgestrel—Fatigue—Timolol—glaucoma	0.000258	0.00039	CcSEcCtD
Levonorgestrel—Pain—Timolol—glaucoma	0.000255	0.000387	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000254	0.00247	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000254	0.00247	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Betaxolol—glaucoma	0.00025	0.000379	CcSEcCtD
Levonorgestrel—Nausea—Clonidine—glaucoma	0.000249	0.000378	CcSEcCtD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—glaucoma	0.000246	0.00238	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000245	0.00238	CbGpPWpGaD
Levonorgestrel—Gastrointestinal pain—Timolol—glaucoma	0.000244	0.00037	CcSEcCtD
Levonorgestrel—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.000242	0.00235	CbGpPWpGaD
Levonorgestrel—Dizziness—Betaxolol—glaucoma	0.000242	0.000367	CcSEcCtD
Levonorgestrel—Urticaria—Timolol—glaucoma	0.000237	0.00036	CcSEcCtD
Levonorgestrel—Body temperature increased—Timolol—glaucoma	0.000236	0.000358	CcSEcCtD
Levonorgestrel—Abdominal pain—Timolol—glaucoma	0.000236	0.000358	CcSEcCtD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000234	0.00227	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000233	0.00226	CbGpPWpGaD
Levonorgestrel—Vomiting—Betaxolol—glaucoma	0.000233	0.000353	CcSEcCtD
Levonorgestrel—Rash—Betaxolol—glaucoma	0.000231	0.00035	CcSEcCtD
Levonorgestrel—Dermatitis—Betaxolol—glaucoma	0.00023	0.000349	CcSEcCtD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000229	0.00223	CbGpPWpGaD
Levonorgestrel—Headache—Betaxolol—glaucoma	0.000229	0.000347	CcSEcCtD
Levonorgestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000229	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000228	0.00221	CbGpPWpGaD
Levonorgestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000226	0.00219	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000221	0.00215	CbGpPWpGaD
Levonorgestrel—Hypersensitivity—Timolol—glaucoma	0.00022	0.000334	CcSEcCtD
Levonorgestrel—Nausea—Betaxolol—glaucoma	0.000217	0.000329	CcSEcCtD
Levonorgestrel—Asthenia—Timolol—glaucoma	0.000214	0.000325	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—GSTM1—glaucoma	0.000212	0.00206	CbGpPWpGaD
Levonorgestrel—Pruritus—Timolol—glaucoma	0.000211	0.00032	CcSEcCtD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000205	0.00199	CbGpPWpGaD
Levonorgestrel—Diarrhoea—Timolol—glaucoma	0.000204	0.00031	CcSEcCtD
Levonorgestrel—ESR1—Signaling by ERBB4—BAD—glaucoma	0.000204	0.00198	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000199	0.00193	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—OPN4—glaucoma	0.000199	0.00193	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000198	0.00192	CbGpPWpGaD
Levonorgestrel—Dizziness—Timolol—glaucoma	0.000198	0.0003	CcSEcCtD
Levonorgestrel—Vomiting—Timolol—glaucoma	0.00019	0.000288	CcSEcCtD
Levonorgestrel—Rash—Timolol—glaucoma	0.000188	0.000286	CcSEcCtD
Levonorgestrel—Dermatitis—Timolol—glaucoma	0.000188	0.000285	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—MTHFR—glaucoma	0.000188	0.00182	CbGpPWpGaD
Levonorgestrel—Headache—Timolol—glaucoma	0.000187	0.000284	CcSEcCtD
Levonorgestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000185	0.0018	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HEYL—glaucoma	0.000185	0.00179	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTGFR—glaucoma	0.000179	0.00174	CbGpPWpGaD
Levonorgestrel—Nausea—Timolol—glaucoma	0.000177	0.000269	CcSEcCtD
Levonorgestrel—SRD5A1—Metabolism—APOE—glaucoma	0.000175	0.0017	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—NR3C1—glaucoma	0.000174	0.00169	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—CAV1—glaucoma	0.000173	0.00168	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00017	0.00165	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—LRP12—glaucoma	0.000168	0.00163	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000166	0.00161	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000162	0.00158	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000154	0.0015	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000154	0.00149	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000151	0.00147	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—VEGFA—glaucoma	0.00015	0.00146	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CA1—glaucoma	0.000145	0.00141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	0.000142	0.00138	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CTSA—glaucoma	0.00014	0.00136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RPTOR—glaucoma	0.00014	0.00136	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NCK2—glaucoma	0.000136	0.00132	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000133	0.00129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CA2—glaucoma	0.000133	0.00129	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—NR3C1—glaucoma	0.000132	0.00129	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—NOS3—glaucoma	0.000131	0.00127	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00013	0.00126	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00013	0.00126	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—TNF—glaucoma	0.000129	0.00125	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000128	0.00124	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000125	0.00122	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000124	0.0012	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—PTGS2—glaucoma	0.00012	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000119	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000119	0.00115	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—glaucoma	0.000117	0.00113	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OPN4—glaucoma	0.000117	0.00113	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	0.000116	0.00113	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HDAC9—glaucoma	0.000115	0.00112	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.00011	0.00106	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HEYL—glaucoma	0.000108	0.00105	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTGFR—glaucoma	0.000105	0.00102	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	0.000102	0.000991	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.0001	0.000975	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	9.86e-05	0.000957	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.84e-05	0.000956	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.71e-05	0.000943	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.67e-05	0.000939	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CDKN2B—glaucoma	9.54e-05	0.000926	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TXN—glaucoma	9.34e-05	0.000907	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SMO—glaucoma	9.03e-05	0.000876	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	8.99e-05	0.000873	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA5A—glaucoma	8.66e-05	0.000841	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NARFL—glaucoma	8.66e-05	0.000841	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	8.52e-05	0.000827	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	8.45e-05	0.00082	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	8.44e-05	0.00082	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NR3C1—glaucoma	8.37e-05	0.000813	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK2—glaucoma	8.26e-05	0.000802	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RPTOR—glaucoma	8.22e-05	0.000798	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NCK2—glaucoma	7.96e-05	0.000773	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.87e-05	0.000764	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.76e-05	0.000754	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	7.45e-05	0.000723	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CDKN2B—glaucoma	7.27e-05	0.000706	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTT1—glaucoma	7.24e-05	0.000703	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGFR—glaucoma	7.08e-05	0.000688	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HDAC9—glaucoma	6.77e-05	0.000657	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK1—glaucoma	6.73e-05	0.000653	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR3C1—glaucoma	6.38e-05	0.000619	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN2B—glaucoma	6.2e-05	0.000602	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EDN1—glaucoma	5.95e-05	0.000578	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.84e-05	0.000567	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP1B1—glaucoma	5.77e-05	0.00056	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCA1—glaucoma	5.77e-05	0.00056	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CDKN2B—glaucoma	5.6e-05	0.000544	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGF—glaucoma	5.47e-05	0.000531	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SMO—glaucoma	5.3e-05	0.000514	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—C3—glaucoma	5.2e-05	0.000505	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—glaucoma	4.91e-05	0.000477	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK2—glaucoma	4.85e-05	0.00047	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—glaucoma	4.84e-05	0.00047	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CAV1—glaucoma	4.8e-05	0.000466	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GSTM1—glaucoma	4.61e-05	0.000448	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FN1—glaucoma	4.56e-05	0.000443	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BAD—glaucoma	4.51e-05	0.000438	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA1—glaucoma	4.23e-05	0.000411	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGFR—glaucoma	4.16e-05	0.000404	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CTSA—glaucoma	4.1e-05	0.000398	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—MTHFR—glaucoma	4.08e-05	0.000396	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK1—glaucoma	3.95e-05	0.000383	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA2—glaucoma	3.87e-05	0.000376	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—glaucoma	3.79e-05	0.000368	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAV1—glaucoma	3.76e-05	0.000365	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN2B—glaucoma	3.64e-05	0.000353	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NOS3—glaucoma	3.63e-05	0.000352	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EDN1—glaucoma	3.49e-05	0.000339	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGF—glaucoma	3.21e-05	0.000312	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1B—glaucoma	3.14e-05	0.000305	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—C3—glaucoma	3.05e-05	0.000296	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—glaucoma	2.91e-05	0.000282	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—NOS3—glaucoma	2.84e-05	0.000276	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—glaucoma	2.84e-05	0.000276	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CAV1—glaucoma	2.81e-05	0.000273	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TXN—glaucoma	2.72e-05	0.000265	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FN1—glaucoma	2.68e-05	0.00026	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BAD—glaucoma	2.65e-05	0.000257	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—glaucoma	2.61e-05	0.000254	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—glaucoma	2.6e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NOS3—glaucoma	2.13e-05	0.000207	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTT1—glaucoma	2.11e-05	0.000205	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—glaucoma	1.97e-05	0.000192	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.84e-05	0.000179	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—glaucoma	1.71e-05	0.000166	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP1B1—glaucoma	1.68e-05	0.000163	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCA1—glaucoma	1.68e-05	0.000163	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—glaucoma	1.53e-05	0.000149	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GSTM1—glaucoma	1.35e-05	0.000131	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—MTHFR—glaucoma	1.19e-05	0.000115	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—glaucoma	1.16e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—glaucoma	1.11e-05	0.000108	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAV1—glaucoma	1.1e-05	0.000107	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NOS3—glaucoma	8.3e-06	8.05e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—glaucoma	7.59e-06	7.37e-05	CbGpPWpGaD
